Track topics on Twitter Track topics that are important to you
Glucagon like peptide1 GLP1 agonists is the agonists of the GLP1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
Market Segment as follows:
By Region / Countries
North America U.S., Canada, Mexico
Europe Germany, U.K., France, Italy, Russia, Spain etc
South America Brazil, Argentina etc
Middle East Africa Saudi Arabia, South Africa etc
By EndUser / Application
Original Article: 20152023 World Glucagon Like Peptide1 GLP1 Agonists Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 15122017] Prices from USD $2800NEXT ARTICLE
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...